Quick-commerce players are rapidly gaining share in acute, event-based medicines
Quick commerce is reshaping pharma distribution. But the real transformation is happening deeper in the supply chain. Uday Kadam,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Report maps non-animal testing methods for drug development in India
Study outlines role of NAMs in pharma and MedTech research
Pinwheel Therapeutics raises $20mn from 108 BioCapital
Funding linked to late-stage clinical asset transaction
Lupin launches Topiramate Extended-Release Capsules in the US
Launch follows FDA approval for ANDA
Zydus receives USFDA tentative approval for dapagliflozin tablets
Approval covers 5 mg and 10 mg strengths for US market
Sun Pharma named principal sponsor and health partner of Royal Challengers Bengaluru
Three-year partnership marks Sun Pharma’s first cricket sponsorship
CDSCO approves durvalumab with FLOT for resectable gastric and GEJ cancer in India
Approval based on phase III MATTERHORN study supports perioperative use
UP Pharma Conclave 1.0 inaugurated in Lucknow; Gov outlines investment and manufacturing roadmap
CM Yogi Adityanath sets out policy framework, law and order measures, and pharma sector plans at investor congregation
Friendshoring: Pharma’s next supply chain bet?
With friendshoring gaining attention in global supply chain conversations, this story looks at what it could mean for the India…
Lupin launches Dasatinib tablets in United States
Lupin announced the launch of Dasatinib tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg, in the United States, following…
SPARC receives Priority Review Voucher associated with Sezaby approval
Sun Pharma Advanced Research Company (SPARC) announced that the United States Food and Drug Administration (FDA) has granted a…
AstraZeneca India receives CDSCO approval for Durvalumab in combination with FLOT chemotherapy
AstraZeneca Pharma India, a global, science-led biopharmaceutical company, announces the Central Drugs Standard Control…
Rx-to-OTC is not a channel shift—it’s a complete business model shift
By 2030, what will truly differentiate winning OTC players in India from the rest?
By 2030, the biggest differentiator for…
Uttar Pradesh gears up to showcase pharma investment opportunities at Pharma Conclave 1.0
The Uttar Pradesh Food Safety and Drug Administration (FSDA) and Invest UP will co-host “Pharma Conclave 1.0: Investment…
Lupin and TB Alliance collaborate to advance Telacebec for treatment of TB and other mycobacterial…
Lupin announced a strategic collaboration with TB Alliance, a nonprofit drug developer, to advance the clinical development and…
Industry calls Union Budget 2026 a defining moment for India’s biopharma future
Industry stakeholders view the Union Budget 2026 as a pivotal inflection point in India’s life sciences journey. With the launch…
Biopharma gets a boost in Budget 2026 with ₹10,000-crore outlay
Biopharma Shakti programme to boost domestic manufacturing of biologics and biosimilars. The Budget also announces customs duty…
Good pharma-focused developers are now co-designing with GMP/WHO/USFDA consultants from day zero
How have pharma companies changed the way they plan and choose real estate after the pandemic? What matters most to them now,…
Local focus to strengthen Indian pharmaceutical manufacturers
Why is localising format part production an important step for Indian pharmaceutical companies and Romaco?
Sanjeev Nimkar: It…
Health ministry amends NDCT Rules, 2019 to reduce regulatory burden and promote ease of doing…
Union Ministry of Health and Family Welfare has notified key amendments to the New Drugs and Clinical Trials (NDCT) Rules, 2019 to…